BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Synox Therapeutics Ltd.

Headquarters: Dublin, Ireland
Year Founded: 2020
Status: Private

BioCentury | Oct 31, 2024
Finance

Axonis advancing KCC2 program with $115M series A

BioCentury’s Venture Report also includes fundings for Evommune, Blue Earth and more
BioCentury | Apr 26, 2024
Finance

Venture report: Arch, Foresite $1B AI play Xaira starting with Baker lab’s de novo biologics 

Plus rounds for Rubedo, Flindr, Endeavor, SynOx and more
BioCentury | Apr 1, 2022
Management Tracks

Morgan Stanley’s Christine Ha becomes CFO at Ventus

Plus new CEO at Zealand Pharma, updates from Nuvalent, Pathalys and more
BioCentury | Aug 4, 2021
Management Tracks

Qian joins LianBio as general manager of China

Hoffman out as Zymergen CEO, plus updates from Scholar Rock, Ironwood, Keros, Madrigal and more 
BioCentury | Jul 28, 2021
Management Tracks

Cassidy joins SpringWorks as CMO

Plus: Centogene, Lava, Umoja and SynOx
BioCentury | Apr 21, 2021
Finance

With upsized opportunity fund closing at €360M, Forbion readies to build on portfolio with three-pronged strategy 

Forbion is carving out a strategy that’s differentiated from most biotech opportunity funds
BioCentury | Nov 19, 2020
Finance

VCs back Celleron spinout with €37M to develop former Roche asset for rare joint disorder

A European VC syndicate shared Celleron’s belief that a single-asset start-up was the best place to develop emactuzumab, an asset the U.K. biotech obtained after Roche deprioritized it in 2018.
Items per page:
1 - 7 of 7